Financial Information
- İntema
- Eczacıbaşı Pharmaceutical and Industrial Investment Co.
- Financial Information
- Announcements and Presentations
- Corporate Governance
- General Assembly
- Investor's Calendar
- Contact Us
- Eczacıbaşı Investment Holding Co.
- Eczacıbaşı Group Annual Report
Financial Highlights
| SUMMARIZED FINANCIAL DATA (Thousand TL) | 2018/09 | 2017/09 | ||
| Revenue | 510,386 | 430,104 | ||
| Gross Profit | 178,794 | 170,742 | ||
| Operating Profit | 256,496 | 85,333 | ||
| Depreciation and Amortisation | 7,844 | 8,073 | ||
| EBITDA | 264,340 | 93,406 | ||
| Net Income | 291,032 | 168,873 | ||
| 2018/09 | 2017/12 | |||
| Total Assets | 4,096,274 | 3,831,375 | ||
| Total Shareholder's Equity | 3,635,588 | 3,480,655 | ||
| Total Current Assets | 972,637 | 741,324 | ||
| Total Current Liabilities | 250,586 | 210,146 | ||
| Capital Expenditures | 10,680 | 20,142 | ||
| Liquidity Ratios (%) | 2018/09 | 2017/12 | ||
| - Current Ratio | 3.88 | 3.53 | ||
| - Liquidity Ratio | 3.60 | 3.18 | ||
| The Ratios Related to Financial Structure (%) | 2018/09 | 2017/12 | ||
| - Total Liabilities / Total Assets | 0.11 | 0.09 | ||
| - Total Shareholders' Equity / Total Assets | 0.89 | 0.91 | ||
| - Total Shareholders' Equity / Total Liabilities | 7.89 | 9.92 | ||
| Profitability Ratios (%) | 2018/09 | 2017/12 | ||
| - Net Income / Total Shareholders' Equity | 0.08 | 0.04 | ||
| - Net Income / Total Assets | 0.07 | 0.04 | ||
| - Net Income / Net Sales | 0.57 | 0.24 | ||